Molson Coors Nominates Julia M. Brown as an Independent Director to Join Its Board of Directors

Molson Coors Nominates Julia M. Brown as an Independent Director to Join Its Board of Directors

GOLDEN, Colo. & MONTREAL–(BUSINESS WIRE)–
The Molson Coors Beverage Company (NYSE: TAP; TSX: TPX) board of directors today announced that Julia M. Brown has been nominated as an independent director for election at the company’s Annual Meeting of Stockholders on May 26, 2021. Brown is a seasoned supply chain and procurement executive who most recently served as the Chief Procurement Officer for Mars Wrigley. The board also announced independent director Iain Napier will not stand for re-election in accordance with the company’s retirement policy and will retire from board service at the meeting.

“We are thrilled to nominate Julia for election to our Board. She is a strategic, engaging, and transformational leader that brings a depth of experience to the boardroom,” said Andrew Molson, chair of the Molson Coors Board of Directors. “Julia’s background will offer unique insights that I believe will be invaluable to our company’s long-term success.”

Brown’s experience spans across strategic sourcing, purchasing, co-manufacturing and logistics. Prior to Mars Wrigley, Brown served as Chief Procurement Officer at Carnival Corporation, where she was responsible for strategic sourcing and supplier relationship management, overseeing nearly $10 billion in corporate expenditures. She has also served as Chief Procurement Officer at Mondelez International, Kraft Foods and The Clorox Company. She has served in purchase leadership positions at The Gillette Company, Diageo and Procter & Gamble.

“I would like to thank the Board for the opportunity to be a part of the future of Molson Coors Beverage Company and have long admired the rich history of Molson Coors,” said Brown. “It’s an exciting time to join this Board and I look forward to the continued growth of this business.”

Brown has been honored as one of the top 100 most “Influential Blacks in Corporate America” by Savoy Magazine, as being among the top 50 Women to Watch by FTSE 100, and as one of Black Enterprise’s Top 75 Most Powerful Women in Business. She currently also serves as a Director for Shutterfly and remains active in non-profit and industry association governance.

Brown earned an Honors Bachelor of Commerce from McMaster University in Hamilton, Canada.

Napier has served on Molson Coors’ Board of Directors since 2008 and has served on the Audit, Finance and Compensation and Human Resources Committee at various times during his tenure on the Board. “On behalf of the entire Board and management, I would like to warmly thank Iain for his highly appreciated services and important contributions to Molson Coors over his thirteen-year tenure as a director,” Andrew Molson said.

About Molson Coors

For over two centuries Molson Coors has been brewing beverages that unite people to celebrate all life’s moments. From Coors Light, Miller Lite, Molson Canadian, Carling, and Staropramen to Coors Banquet, Blue Moon Belgian White, Blue Moon LightSky, Vizzy, Leinenkugel’s Summer Shandy, Creemore Springs, Hop Valley and more, Molson Coors produces many beloved and iconic beer brands. While the company’s history is rooted in beer, Molson Coors offers a modern portfolio that expands beyond the beer aisle as well. The company’s commitment to raising industry standards and leaving a positive imprint on our employees, consumers, communities, and the environment is reflected in Our Imprint and our 2025 sustainability targets. To learn more about Molson Coors Beverage Company, visit molsoncoors.com, MolsonCoorsOurImprint.com or on Twitter through @MolsonCoors.

This press release is not a solicitation of proxies from holders of Class A common stock of Molson Coors Beverage Company (the “Company”) or Class A exchangeable shares of Molson Coors Canada Inc. (“MCC”). Each of the Company and MCC will provide shareholders with a proxy statement and other relevant materials in connection with the 2021 Annual Meeting of Stockholders. Any solicitation of proxies by or on behalf of the Company or MCC in connection with the 2021 Annual Meeting of Stockholders will be conducted upon and following the dissemination of the proxy statement and other materials in accordance with applicable law. We urge stockholders to read the proxy statement and any other relevant documents to be filed with the SEC when available, as such documents will contain important information. Stockholders will be able to receive the proxy statement and other relevant documents free of charge at the SEC’s website at www.sec.gov or at www.molsoncoors.com.

Marty Maloney

[email protected]

773-972-7780

KEYWORDS: United States North America Canada Colorado

INDUSTRY KEYWORDS: Retail Food/Beverage Wine & Spirits

MEDIA:

Logo
Logo

Wolters Kluwer’s Abhishek Mittal Wins 2021 Artificial Intelligence Excellence Award

Wolters Kluwer’s Abhishek Mittal Wins 2021 Artificial Intelligence Excellence Award

Governance, Risk & Compliance division executive one of just five individuals lauded for leading the development of superior AI technology within the legal technology industry

HOUSTON–(BUSINESS WIRE)–
Abhishek Mittal, Vice President, Data Analytics and Operational Excellence, for Wolters Kluwer’s Government, Risk & Compliance division (GRC), has been named a Business Intelligence (BI) Group 2021 Artificial Intelligence Excellence Award winner.

The accolade recognizes Mittal’s leadership in developing and advancing the AI technology that drives many leading innovations for Wolters Kluwer ELM Solutions, including LegalVIEW® BillAnalyzer, LegalVIEW® Predictive Insights, Intelligent Invoice Conversion and CLM Matrix Contract Lifecycle Management.

Mittal, one of just five winners recognized in the Individual category, was instrumental in helping Wolters Kluwer gain a patent for BillAnalyzer’s AI technology, which leverages several model-based predictors to power a legal bill review process that delivers best-in-class results. This technology harnesses LegalVIEW, the world’s largest repository of legal spend data, to provide up to 10 percent cost legal cost savings and up to 20 percent improvement in billing guideline compliance.

The BI Group was founded to recognize exceptional talent and superior performance in the business world. The Artificial Intelligence Excellence Individual Awards recognize executives whose leadership in the organization and industry has led to breakthrough AI solutions.

“I am thrilled that Abhishek has been recognized for his innovative and forward-thinking guidance on many of Wolters Kluwer’s AI-powered solutions,” said Sandeep Sacheti, Executive Vice President, Customer Insights & Operational Excellence for Wolters Kluwer GRC. “Companies are quickly becoming reliant on AI as they modernize their business plans. Abhishek and his team have developed many innovations across legal and regulatory compliance. These innovations deliver real value by improving processes, outcomes, and financial results for our customers.”

Mittal joined Wolters Kluwer in August 2012. He is responsible for leading a diverse and creative team of professionals across data science, design experts, process re-engineering and compliance expertise to drive business transformation and new product innovation. Before joining Wolters Kluwer, Mittal held several management roles at American Express, where he led risk management teams for the small business portfolio.

ELM Solutions, part of Wolters Kluwer GRC, is the market-leading global provider of enterprise legal spend and matter management, contract lifecycle management and legal analytics solutions. The company provides a comprehensive suite of tools that address the growing needs of corporate legal operations departments to increase operational efficiency and reduce costs. Corporate legal and insurance claims departments trust its innovative technology and end-to-end customer experience to drive world-class business outcomes.

Wolters Kluwer’s ELM Solutions was named a leader in both the IDC MarketScape: Worldwide Enterprise Legal Spend Management 2020 Vendor Assessment and IDC MarketScape: Worldwide Enterprise Matter Management 2020 Vendor Assessment. The company’s award-winning products include Passport®, the highest-rated ELM solution in the latest Hyperion MarketViewLegal Market Intelligence Report and TyMetrix® 360°, the industry’s leading SaaS-based e-billing and matter management solution. CLM Matrix, meanwhile, was named a “strong performer” in The Forrester Wave™: Contract Lifecycle Management For All Contracts, Q1 2021 report. ELM Solutions’ LegalVIEW® portfolio of legal analytics solutions is based upon the industry’s largest and most comprehensive legal spend database, with more than $140 billion in invoices.

About Wolters Kluwer Governance, Risk & Compliance

Governance, Risk & Compliance is a division of Wolters Kluwer, which provides legal and banking professionals with solutions to help ensure compliance with ever-changing regulatory and legal obligations, manage risk, increase efficiency, and produce better business outcomes. GRC offers a portfolio of technology-enabled expert services and solutions focused on legal entity compliance, legal operations management, banking product compliance, and banking regulatory compliance.

Wolters Kluwer (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Paul Lyon

Global Corporate Communications Director

Governance, Risk & Compliance Division

Wolters Kluwer

Office +44 20 3197 6586

[email protected]

Andrew Ferraro

Corporate Communications Manager, Legal Solutions

Governance, Risk & Compliance Division

Wolters Kluwer

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Finance Professional Services Legal Technology Software

MEDIA:

Logo
Logo

Knowles Introduces New Line of Automotive-Grade MEMS Microphones, Raises Standard of In-Cabin Audio

Knowles Introduces New Line of Automotive-Grade MEMS Microphones, Raises Standard of In-Cabin Audio

Global leader in MEMS microphones expands portfolio with best-in-class analog and digital microphones for emerging automotive use cases

ITASCA, Ill.–(BUSINESS WIRE)–Knowles Corporation (NYSE: KN), a market leader and global provider of advanced micro-acoustic microphones, speakers, audio processing, and precision device solutions, today announced the availability of two new SiSonicTM MEMS microphones for automotive applications: SPH1878 and SPH9855. The new microphones by Knowles are engineered to a higher standard of quality and supply assurance to support the increasing demands of the automotive market for hands free calling, advanced voice assistance and in-cabin noise cancellation for passenger comfort.

The launch of these latest microphones marks Knowles’ further commitment to the automotive market, building on its industry leading high quality and innovation standards. The microphones follow the AEC-Q100/103 qualification requirements set by the Automotive Electronics Council, the standardization body for establishing standards for reliable, high quality electronic components for use in the harsh automotive environment.

“We are pleased to introduce a new grade of MEMS microphones for the automotive industry. As both consumers and commuters in a connected world, we look forward to providing car and truck makers with additional capabilities to develop better voice call quality and innovative audio features, as well as enable quieter travel for years to come,” says Greg Doll, General Manager and Vice President of Product Management at Knowles. “Diverse supply chains are more important than ever as well. We have our own proprietary MEMS microphone designs that can be scaled from our two multi-national factories at high-volume to provide manufacturing flexibility for our customers.”

SPH1878 features both single-ended and differential analog interface, while SPH9855 features a PDM digital interface. The two microphones are designed for beam forming applications and are compatible with the European eCall communication system. Key features include low phase distortion for superior noise cancelling performance, high dynamic range for enhanced call and sound quality, an extended operating temperature range for automotive applications, and improved manufacturing stability and traceability.

As the MEMS sensors, integrated circuits and packaging for the microphones are all designed in-house, Knowles is in a unique position to offer best-in-class engineering support to customers through its global field application team anywhere in the world.

“We are excited to work with Knowles on our next generation automotive solutions”, said Naoto Abe of Transtron Automotive Array Microphone R&D Group. “Knowles’ latest offering on low phase distortion and high dynamic range gives us the flexibility to use the same microphone for both active noise cancellation and communication systems. Knowles has delivered on their reputation for high quality products with AEC-Q100/103 qualification. We value Knowles’ commitment to the automotive market with their unique ability to design all key mic components.”

The two SiSonic MEMS microphones are currently sampling with customers and are expected to be in production later this year. For additional information, contact your Knowles representative or email [email protected] or visit https://www.knowles.com/sisonic-automotive-microphones/.

About Knowles

Knowles Corporation (NYSE: KN) is a market leader and global provider of advanced micro-acoustic microphones and speakers, audio processing, and precision device solutions, serving the consumer electronics, communications, medtech, defense, electric vehicle, and industrial markets. Knowles uses its leading position in SiSonic™ MEMS (micro-electro-mechanical systems) microphones and strong capabilities in audio processing technologies to optimize audio systems and improve the user experience in mobile, ear, and IoT applications. Knowles is also the leader in acoustic components, high-end capacitors and mmWave RF solutions for a diverse set of markets. Knowles’ focus on the customer, combined with unique technology, proprietary manufacturing techniques, rigorous testing, and global scale, enables it to deliver innovative solutions that optimize the user experience. Founded in 1946 and headquartered in Itasca, Illinois, Knowles is a global organization with employees in over a dozen countries. The company continues to invest in high value solutions to diversify its revenue and increase exposure to high growth markets. For more information, visit knowles.com.

Financial Contact:

Mike Knapp

Knowles Investor Relations

Phone: (630) 238-5236

Email: [email protected]

Press Contact:

Caster Communications, Inc.

Phone: (401) 792-7080

Email: [email protected]

KEYWORDS: North America United States South Korea Asia Pacific Japan Illinois

INDUSTRY KEYWORDS: Technology General Automotive Mobile/Wireless Engineering Audio/Video Automotive Manufacturing Manufacturing Automotive Other Technology Hardware Other Manufacturing Electronic Design Automation Consumer Electronics VoIP

MEDIA:

Logo
Logo

FIS to Report First Quarter Earnings on May 6, 2021

FIS to Report First Quarter Earnings on May 6, 2021

JACKSONVILLE, Fla.–(BUSINESS WIRE)–FIS® (NYSE: FIS), a global leader in financial services technology, will announce first quarter 2021 financial results on Thurs., May 6, 2021, prior to market open.

The company will sponsor a live webcast of its earnings conference call with the investment community beginning at 8:30 a.m. (EDT) the same day. To access the webcast, go to the Investor Relations section of FIS’ homepage, www.fisglobal.com. A replay will be available after the conclusion of the live webcast.

About FIS

FIS is a leading provider of technology solutions for merchants, banks and capital markets firms globally. Our employees are dedicated to advancing the way the world pays, banks and invests by applying our scale, deep expertise and data-driven insights. We help our clients use technology in innovative ways to solve business-critical challenges and deliver superior experiences for their customers. Headquartered in Jacksonville, Florida, FIS is a Fortune 500® company and is a member of Standard & Poor’s 500® Index. To learn more, visit www.fisglobal.com. Follow FIS on Facebook, LinkedIn and Twitter (@FISGlobal).

Kim Snider

Senior Vice President

FIS Global Marketing and Corporate Communications

904.438.6278

[email protected]

Nathan Rozof, CFA

Executive Vice President

FIS Corporate Finance

904.438.6918

[email protected]

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS: Mobile/Wireless Technology Finance Security Banking Other Technology Professional Services Software Networks Data Management

MEDIA:

Logo
Logo

Wipro Limited to Announce Results for the Fourth Quarter Ended March 31, 2021 on April 15, 2021

Wipro Limited to Announce Results for the Fourth Quarter Ended March 31, 2021 on April 15, 2021

BANGALORE, India & EAST BRUNSWICK, N.J.–(BUSINESS WIRE)–
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) a leading global information technology, consulting and business process services company, will announce results for the fourth quarter ended March 31, 2021 on Thursday, April 15, 2021 after stock market trading hours in India. The results will be available in the Investors section of the company’s website at www.wipro.com/investors/

At 7:15 PM IST* (9:45 AM US Eastern time) following the results announcement, the senior management will discuss the company’s performance for the quarter and answer questions sent by 6:30 PM IST* (9:00 AM US Eastern time) to: [email protected] or [email protected]

The audio from the conference call will be available online through a webcast and can be accessed at

https://links.ccwebcast.com/?EventId=WIPRO210415

Dial in details for the conference call are as below:

Time

7.15 PM – IST* (9:45 AM-ET#)

Click here for the diamond pass link

 

Diamond Pass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator.

 

If you have a Diamond Pass™ click the above link to associate your pin and receive the access details for this conference, if you do not have a Diamond Pass™ please register through the link and you will receive your Diamond Pass™ for this conference.

Primary Access Toll Number

+91 22 6280 1120

+91 22 7115 8021

Local Access

Available all over India

+91-7045671221

US Toll Free Number

US Standby Toll Number

1 866 746 2133

1 323 386 8721

UK Toll Free Number

UK Standby Toll Number

0 808 101 1573

44 203 478 5524

No passcode Required

* Indian Standard Time, # US Eastern Time

Please dial any of the above numbers five to ten minutes ahead of schedule. The operator will provide instructions on asking questions before and during the call.

The replay of the call will be available two hours after the end of the call on following numbers:

Call Playback Numbers:

 

Phone Number

Passcode / Conference ID

Replay Dates

India Toll

+91 22 71945757

+91 22 66635757

Access Code: 947765#

15-Apr-21 to 14-May-21

International Toll

+1 8554360715

Access Code: 947765#

15-Apr-21 to 14-May-21

About Wipro Limited

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading global information technology, consulting and business process services company. We harness the power of cognitive computing, hyper-automation, robotics, cloud, analytics and emerging technologies to help our clients adapt to the digital world and make them successful. A company recognized globally for its comprehensive portfolio of services, strong commitment to sustainability and good corporate citizenship, we have over 190,000 dedicated employees serving clients across six continents. Together, we discover ideas and connect the dots to build a better and a bold new future.

Aparna C Iyer

+91 9845540884

KEYWORDS: New Jersey United States India North America Asia Pacific

INDUSTRY KEYWORDS: Mobile/Wireless Technology Consulting Other Technology Professional Services Software Networks Internet Hardware Data Management

MEDIA:

Logo
Logo

CACI Awarded Multiple-Award $700 Million Blanket Purchase Agreement to Provide National Security Investigations to Department of Homeland Security

CACI Awarded Multiple-Award $700 Million Blanket Purchase Agreement to Provide National Security Investigations to Department of Homeland Security

ARLINGTON, Va.–(BUSINESS WIRE)–
CACI International Inc (NYSE: CACI) announced today that it has been awarded a five-year, multiple-award Blanket Purchase Agreement (BPA) by the U.S. Department of Homeland Security (DHS), with a $700 million total federal program value, to provide national security investigations to the department.

Under the agreement, which represents new work for the company, CACI will provide enterprise technology to DHS in support of its national security investigations. CACI will support the full range of case types for DHS and their components. This award also expands the set of government customers to whom CACI provides national security investigations, which includes the U.S. Department of Defense (DoD) and Intelligence Community (IC).

CACI’s efficient investigations business model is a true differentiator. CACI uses a scalable delivery model and stations investigators around the country, ensuring industry-leading training, shared lessons learned, and the delivery of higher quality and more timely work.

John Mengucci, CACI President and Chief Executive Officer, said, “CACI looks forward to applying its more than 17 years of experience supporting national security investigations to help protect the Department of Homeland Security and the integrity of its people and mission.”

CACI’s approximately 23,000 talented employees are vigilant in providing the unique expertise and distinctive technology that address our customers’ greatest enterprise and mission challenges. Our culture of good character, innovation, and excellence drives our success and earns us recognition as a Fortune World’s Most Admired Company. As a member of the Fortune 1000 Largest Companies, the Russell 1000 Index, and the S&P MidCap 400 Index, we consistently deliver strong shareholder value. Visit us at www.caci.com.

There are statements made herein which do not address historical facts, and therefore could be interpreted to be forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to factors that could cause actual results to differ materially from anticipated results. The factors that could cause actual results to differ materially from those anticipated include, but are not limited to, the risk factors set forth in CACI’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020, and other such filings that CACI makes with the Securities and Exchange Commission from time to time. Any forward-looking statements should not be unduly relied upon and only speak as of the date hereof.

CACI-Contract Award

Corporate Communications and Media:

Jody Brown, Executive Vice President, Public Relations

(703) 841-7801, [email protected]

Investor Relations:

Daniel Leckburg, Senior Vice President, Investor Relations

(703) 841-7666, [email protected]

KEYWORDS: United States North America Virginia

INDUSTRY KEYWORDS: Software Networks Other Defense Contracts Technology Defense Security Homeland Security Aerospace Other Technology Manufacturing Public Policy/Government

MEDIA:

Logo
Logo

DoubleVerify Taps Doug Campbell As New Chief Strategy Officer

Industry veteran to spearhead global corporate strategy and development, leveraging over two decades of experience growing public and private companies in advertising technology, connected TV (CTV) and over-the-top (OTT) video

NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) — DoubleVerify (“DV”), a leading software platform for digital media measurement, data and analytics, today announced the appointment of Doug Campbell as Chief Strategy Officer. In his role, Campbell will be responsible for global strategy and corporate development. He will report to Mark Zagorski, CEO of DoubleVerify.

“I’m excited to add Doug to our outstanding senior leadership team,” said Zagorski. “From Magnite to Nielsen, he has demonstrated a track record of success and achievement, and brings exceptional experience and knowledge to the Chief Strategy Officer role. I look forward to Doug’s leadership as we continue to build momentum, expand globally and deliver on our mission to build a stronger, safer and more secure digital advertising ecosystem.”

Campbell has more than two decades of experience successfully growing public and private companies in the arenas of advertising technology, connected TV (CTV) and over-the-top (OTT) video, digital measurement, data analytics, and software-as-a-service (SaaS). Prior to joining DV, he was Chief Strategy Officer at Telaria (NYSE: TLRA), where he oversaw the successful merger with Rubicon Project (NYSE: RUBI) and the acquisition of SpotX to form Magnite (NASDAQ: MGNI) – the largest global, independent sell-side platform.

Previously, Campbell was Chief Operating Officer at eXelate where he led the sale of the company to Nielsen (NYSE: NLSN) and went on to serve as Nielsen’s Senior Vice President of Global Strategy and Corporate Development, where he oversaw strategic acquisitions in digital media and consumer measurement. Prior to eXelate, he was an entrepreneur and held various leadership positions at local digital media pioneer, WorldNow. Campbell began his career as an investment banker at Merrill Lynch.

“I’m thrilled to join a company as trusted and innovative as DoubleVerify,” said Campbell. “DV has taken the lead in providing sophisticated measurement solutions that power media quality and performance in virtually every media environment – including priority, high growth channels like CTV. I look forward to leveraging my industry experience to help strengthen our leadership position globally and accelerate company growth.”

For more information about DoubleVerify, contact [email protected].

About DoubleVerify

DoubleVerify is a leading software platform for digital media measurement and analytics. DoubleVerify’s mission is to make the digital advertising ecosystem stronger, safer and more secure. Through our software platform and the metrics it provides, we help preserve the fair value exchange in the digital advertising marketplace – offering advertisers unbiased data analytics to drive campaign quality and effectiveness, and maximize return on their digital advertising investments. Since 2008, DoubleVerify has helped hundreds of Fortune 500 companies gain the most from their media spend by delivering best in class solutions across the digital advertising ecosystem, helping to build a better industry.



DGTL Activates Advocacy Campaign for Front-Line Health Care Workers

Campaign Enlisted USA Health Care Workers as Influencers to Promote Support Services and Best Practices in Managing the Global Pandemic

NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) — via InvestorWire – DGTL Holdings Inc. (TSXV: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L) (“DGTL” or the “Company”) reports that its wholly owned subsidiary, Hashoff LLC, has completed a national public service announcement campaign with a task force of top U.S. health care professional advocacy organizations. The campaign focused on promoting a new online support service portal for front-line workers and building social community among health care professionals.

The campaign was led by an organization that has championed the interests of registered nurses across the U.S.A. for more than 100 years, providing advocacy, career development and training as well as support services. This group of leading health care professional associations built a task force committee to develop and deploy online tools to support front-line health care workers in coping with the workplace pressures and challenges brought on by the pandemic.

This task force enlisted Hashoff to create an advocacy campaign using content creators from the health care community to create awareness and promote adoption of the tools. Health care professionals have built a formidable online social media community and have been active in sharing their stories, key learnings and best practices and pointing registered nurses to an online portal with support services for these front-line workers.

Health care workers were enlisted to be content creators and were onboarded into the Hashoff platform. The campaign centered on publishing unique and organic content surrounding real-life stories of front-line health care workers and sought to drive traffic to the online health care support portals. The campaign report included an outpouring of gratitude from health care workers toward the associations for providing these tools.

The campaign was successful in generating both reach and engagement. The strong performance has led to multiple requests for proposals for additional campaigns from the task force and the health care organizations that make up its membership.

For more information, visit https://dgtlinc.com or contact:

Investor Relations

John Belfontaine, Director

Email: [email protected]
Phone: +1 (877) 879-3485

DGTL HOLDINGS INC.

DGTL Holdings Inc. acquires and accelerates transformative digital media, marketing and advertising software technologies powered by Artificial Intelligence (AI). DGTL (i.e., Digital Growth Technologies and Licensing) specializes in accelerating fully commercialized enterprise-level SaaS (software-as-a-service) companies in the sectors of content, analytics and distribution via a blend of unique capitalization structures. DGTL Holdings Inc. is traded on the Toronto Venture Exchange as “DGTL,” the OTCQB exchange as “DGTHF” and the Frankfurt Stock Exchange as “A2QB0L.”

For more information, visit https://dgtlinc.com/investors.

HASHOFF LLC

As a wholly owned subsidiary of DGTL Holdings Inc., Hashoff is an enterprise-level self-service CaaS (content-as-a-service) built on proprietary Artificial Intelligence and Machine Learning (AI-ML) technology. Hashoff’s AI-ML platform functions as a full-service content management system designed to empower global brands by identifying, optimizing, engaging, managing and tracking top-ranked digital content publishers for localized brand marketing campaigns. Hashoff is fully commercialized and currently serves numerous global brands by providing direct access to the global gig economy of over 150 million freelance content creators.

Hashoff’s customer portfolio includes global brands in a range of key growth categories, including Anheuser Busch-InBev, Nestle, Post Holdings, Danone and Keurig-Dr. Pepper, Dunkin Brands, The Container Store, TJ Maxx, Ulta Beauty and Pizza Hut Live Nation, The CW, Scribd, Syneos Health and Novartis, etc.iWatch the Hashoff investor video by visiting: https://dgtlinc.com/technology/social-media-cms/.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

__________________________________
i
Current and past customers

Corporate Communications:

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]



New Bow River Capital Evergreen Fund Crosses $100 million in Assets Under Management

DENVER, April 08, 2021 (GLOBE NEWSWIRE) — Bow River Capital, a Denver-based private alternative asset management company, is pleased to announce that its recently launched Evergreen Fund (“the Fund”) has exceeded $100 million in assets after less than a year of operations. The Fund was launched in May 2020 and in a single investment presents a unique opportunity to access institutional-quality private equity investments, with broad exposure and low investment minimums.

“The Evergreen Fund brings our specialized knowledge and private market experience to a wider investor base, many of whom historically have had difficulty accessing the asset class,” said Jeremy Held, Managing Director at Bow River Capital. “The concept has really resonated with our clients. We believe the combination of access to private equity investments, along with the shareholder-friendly features of a registered fund, will continue to attract interest from investors and the advisors who serve them.”

The Fund accepts $50,000 minimum subscriptions on a monthly basis from accredited investors and unlike traditional private equity funds that invest capital over a period of months or years, subscriptions into the Evergreen Fund are immediately invested. Beyond providing a solution for individuals who historically haven’t had access to private equity, the evergreen nature of the Fund provides investors with a better tool to customize their overall exposure to the asset class.

Since inception the Fund has executed more than 25 transactions in the private equity and private credit sector, providing exposure to hundreds of underlying companies and a broad range of private equity sponsors.

“Our investor base has been looking for a solution that leverages our private equity expertise in a vehicle with more liquidity and diversification than a typical private equity fund,” said Bow River Capital President Rich Wham.

Investors have also been attracted to the Fund’s flexible investment mandate which invests directly into middle market companies and private equity secondaries. This unique combination has yielded strong early returns for the Fund’s investors – as of March 31, 2021 the Fund has returned 27.1% since inception on May 22, 2020.

“We are pleased with how the portfolio has developed since the Fund’s launch last year,” said Held. “While early performance has largely been driven by our ability to transact in the less efficient segments of the secondary market, we are most excited about the potential for our direct investments, the majority of which are still held at cost in the portfolio.”

Bow River Capital has developed a successful private equity track record with nearly two decades of experience underwriting and investing in private companies. In addition, Bow River’s investment team has extensive experience managing both evergreen private equity strategies and registered funds. To complement Bow River’s team, the Fund has partnered with Aksia, a leading global private equity consulting firm that brings institutional-quality sourcing and research capabilities.

If you would like to receive additional information on our Fund or have any questions, please contact us at: [email protected]

An offer can only be made by the prospectus and only in jurisdictions in which such an offer would be lawful. The prospectus contains important information concerning risk factors and other material aspects of the Fund to carefully consider, and must be read carefully before a decision to invest is made. An investor should consider the fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund’s prospectus. To obtain a prospectus please visit

www.bowriverevergreen.com

. Read the prospectus carefully before investing.

Any person subscribing for an investment must be able to bear the risks involved and must meet the suitability requirements of the Fund. Investors could lose all or a substantial amount of their investment. No assurance can be given that the Fund’s investment objectives will be achieved. The Fund is speculative and involves a substantial degree of risk. The Fund is a closed-end, non-diversified management investment company that will make periodic repurchase offers for its securities, and is highly illiquid. There is no secondary market for investors’ interests and none is expected to develop. There are certain restrictions on transferring interests. Fees and expenses will offset the Fund’s trading profits. The Fund is subject to conflicts of interest. Other risks include those related to equity securities, fixed income securities, high-yield/high risk bonds, listed private equity, listed infrastructure securities, foreign securities, derivative instruments, leverage, capital calls, investment manager risk, as well as those related to general economic and market conditions, all of which may present significant risks. Please see the prospectus for more information on these and other risks.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein. The Gross expense ratio of the fund is 2.25%. To obtain performance information to the most recent month-end, visit
www.bowriverevergreen.com.

About Bow River Capital

Bow River Capital is a private alternative asset management company based in Denver, Colorado, focused on investing in the lower middle market in three asset classes, including private equity, real estate, and software growth equity. For more information on Bow River, please visit www.bowrivercapital.com.

Distributor: Foreside Fund Distributors, LLC



Press Contact:

Jennifer Levesque

[email protected]

(303) 861 – 8466

Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women

NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) — Last Chance for Children’s (LCFC) Mission is to help save children’s lives anywhere in the world. Due to the COVID-19 pandemic we are now focusing our efforts to help eradicate this virus so we could safely and effectively vaccinate children in need.

Why do we need a COVID-19 Vaccine for Children and Pregnant Women?

Children’s lives have been completely disrupted by the coronavirus pandemic. To date, none of the vaccines against COVID-19 are approved by the FDA for use in children under 12 years old or pregnant women.

The current vaccines approved for emergency use did not enroll children nor pregnant women in their original clinical trials, so data on the safety of these vaccines in these populations is sorely lacking. As pregnant women have a 70% increased risk of severe COVID disease, a safe vaccine is desperately needed. And even though children do not generally get severe COVID, the lack of a vaccine is keeping kids out of school, limiting social interaction, and potentially leaving many kids behind. Plus, if we want to reach herd immunity necessary to eradicate the pandemic, we need to vaccinate kids.

Furthermore, most of these vaccines are based on gene therapy using RNA and DNA vectors that have unknown questions on duration of protection and long-term safety. The NuGenerex Immuno-Oncology Ii-Key-SARS-CoV-2 vaccine is based on natural amino acids using sequences that mimic the coronavirus spike and structural proteins, and selectively regulate select immune responses that are targeted specifically against the SARS-CoV-2 virus without using genetic material.

Generex Biotechnology Corporation’s majority owned public company NuGenerex Immuno-Oncology, Inc. (“NGIO”) is developing the Ii-Key-SARS-CoV-2 vaccine with a special emphasis on the development of a safe and effective vaccine for the pediatric population and for pregnant women, populations with significant unmet need in the COVID vaccine race. The company has completed GMP manufacturing of its Ii-Key-SARS-CoV-2 peptides and plans to submit its FDA IND to initiate clinical trials as soon as possible. NGIO’s goal is to start the pediatric clinical trials by the Fall of 2021.

A Proven Safe & Effective Vaccine

The FDA recognizes the safety profile of the Ii-Key vaccine platform, which has been safely tested in hundreds of people. Generex/NGIO’s other Ii-Key vaccines AE37 for cancer and Ii-Key-H1 for influenza are based on the Ii-Key platform used to develop the Ii-Key-SARS-CoV-2 vaccine. These immunotherapeutic vaccines have been shown to be safe in clinical trials involving hundreds of healthy volunteers and cancer patients. Additionally, the AE37 vaccine has been shown to generate long-term immune memory responses and has demonstrated benefit in disease-free survival in late-stage breast cancer patients.

Anthony S. Crisci, Founder, President, and Chief Executive Officer of Last Chance for Children commented, “After months of research, education and understanding the unmet need for children, particularly children under 12 and pregnant woman from underserved populations globally in medical need. We are proud to announce we have selected the Generex/NuGenerex COVID-19 Vaccine because of the high probability of success and most importantly because of its proven safety record, NGIO’s vaccine is based on natural amino acids. NuGenerex Immuno-Oncology, Inc.’s (NGIO’s) proprietary Ii-Key technology offers a SAFE rapid path to human protection from the COVID-19 pandemic, and the long-term safety profile of Ii-Key vaccines enables NGIO to rapidly develop COVID vaccines for our most valued assets, our children and pregnant women.”


The collaboration between Generex/NuGenerex and Last Chance for Children allows for select children and pregnant women to get NGIO’s vaccine at a special 50 percent off cost…
if, and once, approved by the FDA and made available to the public.

Last Chance for Children is committed to raising the necessary funds, in a fully transparent and fully disclosed model, to directly support NGIO in conducting the clinical trials required by FDA. We are following a St. Jude’s model so that 84% of donations will be targeted for our cause and the remaining 16% will go to LCFC’s administration. The more money Last Chance for Children raises for the clinical development of a safe and effective COVID-19 vaccine, the faster we can reach herd immunity and get back to a sense of normalcy. All use of donated funds shall be disclosed on Last Chance for Children’s website: www.lastchanceforchildren.org

Please visit our website https://www.lastchanceforchildren.org and our Go Fund Me page https://charity.gofundme.com/o/en/campaign/covid-19-vaccine-for-children-and-pregnant-women. This contribution is tax deductible and will save our most important assets, our pregnant mothers and their children and all children, while making sure our elderly are safe around their families and loved ones.

About Last Chance for Children

Last Chance for Children (LCFC), founded in March 2011, is a 501(c)(3) Non-Profit that steps in where the major disease foundations have fallen short in providing direct comfort and support to the Children and Families affected by life threatening diseases…and real Hope for a Cure. The major foundations are focused more on providing information or grants for sometimes arcane academic research while LCFC is actively evaluating public and private companies committed to bringing a cure to market. Please visit our website for more information https://www.lastchanceforchildren.org

About Generex Biotechnology Corp.

Generex Biotechnology Corporation (OTCQB: GNBT) is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. Please visit, https://www.generex.com for more information.

About NuGenerex Immuno-Oncology

NuGenerex Immuno-Oncology, a subsidiary of Generex Biotechnology, is a clinical stage oncology company developing immunotherapeutic peptide vaccines for cancer and infectious disease based on the CD4 T-Cell activation platform, Ii-Key. NuGenerex Immuno-Oncology (NGIO) has been spun out of Generex as a separate public company to advance the platform Ii-Key technology, particularly in combination with the immune checkpoint inhibitors for the treatment of cancer. NGIO is currently engaged in a Phase II clinical trial of its lead cancer immunotherapeutic vaccine AE37 in combination with pembrolizumab (Merck’s Keytruda®) for the treatment of triple negative breast cancer. The company has also turned its Ii-Key technology on infectious disease, responding to the coronavirus pandemic with a SARS-CoV-2 vaccine development program. Please visit our website at: https://www.nugenerexio.com.

Last Chance for Children Contact:

Anthony S. Crisci, Esq., CPA
President and CEO
Last Chance for Children
Tel: 914.417.9706
Email: [email protected]
Fax: 818.301.5165
www.lastchanceforchildren.org

Generex Contact:

Todd Falls
Tel: 1-800-391-6755 Extension 222
Email: [email protected]